Get the Stockscreener App
13.43
0.07%
0.010
After Hours:
13.39
-0.04
-0.30%
Organon Co stock is traded at $13.43, with a volume of 2.05M.
It is up +0.07% in the last 24 hours and up +46.94% over the past month.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
See More
Previous Close:
$13.42
Open:
$13.43
24h Volume:
2.05M
Relative Volume:
0.24
Market Cap:
$3.53B
Revenue:
$6.16B
Net Income/Loss:
$246.00M
P/E Ratio:
14.31
EPS:
0.9387
Net Cash Flow:
$708.00M
1W Performance:
+0.22%
1M Performance:
+46.94%
6M Performance:
+86.53%
1Y Performance:
+54.55%
1-Day Range:
$13.42
$13.46
1-Week Range:
$13.40
$13.48
52-Week Range:
$5.69
$13.48
Organon Co Stock (OGN) Company Profile
Name
Organon Co
Sector
Industry
Phone
551-430-6000
Address
30 HUDSON STREET, JERSEY CITY
Compare OGN vs LLY, JNJ, ABBV, MRK, AZN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
13.43 | 3.52B | 6.16B | 246.00M | 708.00M | 0.9387 |
LLY
Lilly Eli Co
|
1,065.00 | 928.88B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
234.34 | 557.82B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
215.70 | 378.98B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
122.41 | 286.20B | 65.51B | 8.93B | 14.12B | 3.5532 |
AZN
Astrazeneca Plc
|
187.03 | 294.27B | 60.48B | 10.40B | 8.05B | 3.3297 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Underweight |
| Oct-27-25 | Downgrade | Piper Sandler | Overweight → Underweight |
| May-02-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-06-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-03-23 | Downgrade | Goldman | Buy → Neutral |
| Sep-21-23 | Initiated | Barclays | Overweight |
| Mar-16-23 | Initiated | Raymond James | Outperform |
| Oct-14-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-06-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-27-22 | Initiated | Goldman | Buy |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-07-21 | Initiated | Piper Sandler | Neutral |
| Sep-01-21 | Initiated | BofA Securities | Buy |
| Jul-22-21 | Initiated | Citigroup | Buy |
| Jun-15-21 | Initiated | JP Morgan | Neutral |
| Jun-11-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jun-10-21 | Initiated | Evercore ISI | Outperform |
View All
Organon Co Stock (OGN) Latest News
Sun Pharma to Acquire Organon for $11.75 Billion in All-Cash Transaction - The Healthcare Technology Report.
Sun Pharma, Coforge: Indian businesses go shopping abroad as growth slows at home - BBC
Organon & Co is the best performing healthcare stock in April - MSN
Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration deal - The Economic Times
Top Organon & Co. (OGN) Competitors 2026 - MarketBeat
Hanmi Pharmaceutical Faz Parceria com a Organon para Exportação de Terapias de Combinação para o Sudeste Asiático - GlobeNewswire Inc.
What Sparked Organon's Recent Stock Surge - Kavout
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia - Macau Business
OGN Stock Price, Quote & Chart | ORGANON & CO (NYSE:OGN) - ChartMill
Organon (OGN) price target increased by 25.58% to 11.02 - MSN
OGN Stock Chart | ORGANON & CO (NYSE:OGN) - ChartMill
10 Incredible Facts About Sun Pharma’s Historic $11.75 Billion Organon Acquisition - AOL.com
Organon & Co. (OGN) Leads Mid-Cap Stocks with Low Forward P/E Ra - GuruFocus
Sun Pharma’s $11.75 billion Organon bet marks India Inc’s biggest pharma buy - MSN
Organon & Co stock hits 52-week high at $13.44 By Investing.com - Investing.com Nigeria
Organon & Co. (OGN) is attracting investor attention: Here is what you should know - MSN
Organon & Co stock hits 52-week high at $13.44 - Investing.com
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
1OGN.MI Stock Price, Quote & Chart | ORGANON & CO (BIT:1OGN) - ChartMill
Organon to Present New Research on Access and Value at ISPOR 2026 - BioSpace
Sun Pharma's $11.75-billion Organon deal: What it means for Indian pharma M&As - MSN
Organon jumps 15% as Sun Pharma agrees $11.8bn buyout - MSN
Why is OGN stock rising in pre-market today? - MSN
Sun Pharma to buy Organon in $11.75B deal, expanding global reach - MSN
Organon & Co. (NYSE:OGN) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Raises Stock Holdings in Organon & Co. $OGN - MarketBeat
BT explainer: Why Sun Pharma's $11.75-bn Organon deal is priced below past pharma acquisitions - MSN
OGNOrganon & Co Stock Price and Quote - Finviz
Organon & Co(OGN) Stock Options Chain | Quotes & News - Moomoo
Sun Pharma to acquire Organon for $11.75bn - MSN
Sun Pharma to acquire Organon in $11.75 billion all-cash deal - MSN
Sun Pharmaceutical Industries jumps 7% on $11.75 bn Organon & Co. buyout - MSN
Notable healthcare headlines for the week: J&J, Abbott and Organon in focus - MSN
Liquidity Mapping Around (OGN) Price Events - Stock Traders Daily
Earnings snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook - MSN
India's Sun Pharma to buy Organon in $11.75 billion all-cash deal - MSN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisition - MSN
Organon & Co (OGN) Stock Price Quote Today & Current Price Chart - Capital.com
Sun Pharma secures bridge loan for $12 billion Organon purchase - MSN
India’s Sun Pharma plots $12 billion Organon buyout for global reach - MSN
Sun Pharma shares jump 9% as $11.75‑billion Organon buy seals entry into biosimilars, deal expected to close in 2027 - MSN
Organon & Co (OGN) News Flow - Moomoo
Organon Co Stock (OGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.19%
2.96%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):